Response to antiseizure medications in epileptic patients with malformation of cortical development

BACKGROUND: Malformation of cortical development (MCD) is one of the most common causes of pharmacoresistant epilepsy. Improving the knowledge of antiseizure medications (ASMs) treatment response in epileptic patients with MCD is crucial for optimal treatment options, either pharmacological therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Jin, Bo, Aung, Thandar, He, Chenmin, Chen, Cong, Wang, Shan, Ding, Yao, Ding, Fang, Wang, Chao, Li, Hong, Jiang, Biao, Zheng, Zhe, Dai, Haibin, Zhu, Junming, Geng, Yu, Ding, Meiping, Wang, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521419/
https://www.ncbi.nlm.nih.gov/pubmed/34671424
http://dx.doi.org/10.1177/17562864211050027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521419/
https://www.ncbi.nlm.nih.gov/pubmed/34671424
http://dx.doi.org/10.1177/17562864211050027

Ejemplares similares